Scarica l'app Stockscreener
17.69
1.26%
0.26
Precedente Chiudi:
$17.43
Aprire:
$17.49
Volume 24 ore:
2.29M
Relative Volume:
0.40
Capitalizzazione di mercato:
$8.79B
Reddito:
$4.45B
Utile/perdita netta:
$205.00M
Rapporto P/E:
44.23
EPS:
0.4
Flusso di cassa netto:
$372.00M
1 W Prestazione:
+26.52%
1M Prestazione:
+18.46%
6M Prestazione:
+51.37%
1 anno Prestazione:
+26.61%
Intervallo 1D:
$17.42
$17.80
Intervallo di 1 settimana:
$15.50
$17.80
Portata 52W:
$8.02
$17.80
Elanco Animal Health Inc Stock (ELAN) Company Profile
Nome
Elanco Animal Health Inc
Settore
Telefono
877-352-6261
Indirizzo
2500 INNOVATION WAY, GREENFIELD
Confronta ELAN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ELAN
Elanco Animal Health Inc
|
17.69 | 8.50B | 4.45B | 205.00M | 372.00M | 0.40 |
|
ZTS
Zoetis Inc
|
151.71 | 66.04B | 9.39B | 2.61B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.74 | 45.57B | 29.98B | 958.27M | 5.31B | 0.2964 |
|
HLN
Haleon Plc Adr
|
9.6901 | 42.50B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.16 | 18.84B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
308.62 | 13.59B | 2.99B | 1.21B | 1.13B | 25.06 |
Elanco Animal Health Inc Stock (ELAN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-17 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2025-06-26 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2024-12-09 | Iniziato | UBS | Buy |
| 2024-12-02 | Iniziato | Leerink Partners | Market Perform |
| 2024-09-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2024-01-05 | Aggiornamento | Stifel | Hold → Buy |
| 2023-12-19 | Iniziato | Jefferies | Buy |
| 2023-12-15 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2023-12-07 | Iniziato | Exane BNP Paribas | Outperform |
| 2023-04-20 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2022-08-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-16 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-07-21 | Downgrade | Goldman | Buy → Sell |
| 2022-07-12 | Iniziato | Piper Sandler | Neutral |
| 2021-11-18 | Iniziato | Morgan Stanley | Overweight |
| 2021-10-28 | Downgrade | Stifel | Buy → Hold |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-06-15 | Aggiornamento | Cleveland Research | Underperform → Neutral |
| 2021-05-11 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2021-05-11 | Aggiornamento | Gabelli & Co | Hold → Buy |
| 2021-04-15 | Iniziato | Stifel | Buy |
| 2021-03-22 | Downgrade | Gabelli & Co | Buy → Hold |
| 2021-02-26 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2020-12-09 | Downgrade | Argus | Buy → Hold |
| 2020-11-09 | Downgrade | Barclays | Overweight → Underweight |
| 2020-08-20 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-08-13 | Ripresa | Credit Suisse | Neutral |
| 2020-08-04 | Ripresa | Goldman | Buy |
| 2020-07-27 | Downgrade | Cleveland Research | Neutral → Underperform |
| 2020-04-02 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-10 | Iniziato | Raymond James | Mkt Perform |
| 2019-12-19 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-11-07 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2019-09-23 | Iniziato | Barclays | Overweight |
| 2019-08-26 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2019-08-15 | Aggiornamento | UBS | Sell → Neutral |
| 2019-05-23 | Iniziato | Guggenheim | Neutral |
| 2019-03-18 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-03-13 | Ripresa | Morgan Stanley | Equal-Weight |
| 2019-02-12 | Iniziato | William Blair | Mkt Perform |
| 2019-01-23 | Iniziato | UBS | Sell |
| 2019-01-15 | Iniziato | Argus | Buy |
| 2018-10-15 | Iniziato | Morgan Stanley | Equal-Weight |
Mostra tutto
Elanco Animal Health Inc Borsa (ELAN) Ultime notizie
Elanco spearheads Nutrition Secure Indianapolis initiative to provide food aid - Inside INdiana Business
Dogs Vaccines Market Exclusive Report with Detailed Study - openPR.com
Elanco’s Q2 2025 Return to Profitability Signals Growth - Zenopa
Leerink Partners Keeps Buy Rating on Elanco Animal Health with $20 Price Target - AInvest
ELAN Q2 Deep Dive: Innovation and Execution Drive Raised Full-Year Outlook - FinancialContent
Price Consolidation Hints at Upcoming Move in Elanco Animal Health IncorporatedReversal Alert Based on RSI Indicator Confirmed - metal.it
Elanco (ELAN) Jumps 19.7% to Record High on Earnings Boost - MSN
Elanco Animal Health Surges 9% on Q2 Results and Optimistic Full-Year Forecast - AInvest
Elanco Animal Health: Analyst Sentiment Analysis and 12-Month Price Targets - AInvest
Elanco Animal Health Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Elanco Animal Health Incorporated (NYSE:ELAN) Q2 2025 Earnings Call Transcript - Insider Monkey
Elanco Animal Health (ELAN) Gets a Buy from Bank of America Securities - The Globe and Mail
Elanco Animal Health Reports Strong Q2 2025 Results - The Globe and Mail
Chart based analysis of Elanco Animal Health Incorporated trendsTrend Confirmation Scanner with Entry Focus - Newser
ICYMI: Elanco Shares Jump After 2Q Beat-and-Raise Results - iHeart
Elanco Puppy Virus Treatment Expanded With USDA Approval - InkFreeNews.com
UBS Raises PT to $19 for Elanco Animal Health Amid Bullish Outlook - AInvest
A Quick Look at Today's Ratings for Elanco Animal Health(ELAN.US), With a Forecast Between $15 to $21 - 富途牛牛
An Intrinsic Calculation For Elanco Animal Health Incorporated (NYSE:ELAN) Suggests It's 36% Undervalued - Yahoo Finance
Elanco Animal Health shares fall 1.40% premarket after beating Q2 revenue estimates and raising FY guidance. - AInvest
What institutional flow reveals about Elanco Animal Health IncorporatedStrong Buy Signal Summary with Entry Zone - Newser
Elanco Animal Health Inc (ELAN) Q2 2025 Earnings Call Highlights: Strong Pet Health Growth and ... By GuruFocus - Investing.com Canada
Elanco Animal Health 2025 Q2 Earnings Strong Performance as Net Income Surges 122% - AInvest
Elanco Raises 2025 Innovation Revenue Outlook to $720M-$800M, Signals Margin Expansion Through New Launches. - AInvest
10 Hot Stocks Making Winning Look Easy - Insider Monkey
Elanco (ELAN) Q2 Revenue Jumps 5% - AOL.com
Elanco's Q2 2025 Earnings Call: Unraveling Key Contradictions in FX Impact, Innovation Growth, and Margin Dynamics - AInvest
Elanco Animal Health Q2 2025: Innovation-Driven Growth and Accelerated Deleveraging Justify a Buy Rating - AInvest
Elanco Animal Health shares fall 1.55% after-hours despite beating Q2 revenue estimates and raising FY guidance. - AInvest
Elanco's Q2 Revenue Exceeds Expectations, Raises Full-Year Guidance - AInvest
Elanco bolsters parvovirus treatment with new approval - Inside INdiana Business
Elanco (NYSE:ELAN) Delivers Impressive Q2, Stock Jumps 15.4% - Yahoo Finance
Elanco Animal Health Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Earnings call transcript: Elanco Animal Health beats Q2 2025 expectations By Investing.com - Investing.com Canada
Elanco Animal Health Incorporated (ELAN) Q2 Earnings and Revenues Beat Estimates - MSN
Why Is Elanco Animal Health Stock Soaring Thursday?Elanco Animal Health (NYSE:ELAN) - Benzinga
Elanco Animal Health stock hits 52-week high at $15.79 By Investing.com - Investing.com Canada
Elanco Animal Health (ELAN) Reports Q2 Earnings: What Key Metrics Have to Say - Yahoo Finance
Elanco Animal Health Inc SEC 10-Q Report - TradingView
Elanco stock spikes after Q2 beat, guidance raise (ELAN:NYSE) - Seeking Alpha
Elanco Animal Health’s Stock Faces Unusual Movement - TipRanks
Elanco (ELAN) Q2 Revenue Jumps 5% - The Motley Fool
Elanco Animal Health earnings beat by $0.06, revenue topped estimates - Investing.com Canada
Elanco Q2 2025 slides: 8% organic growth drives raised guidance despite headwinds - Investing.com Canada
Elanco Animal Health beats Q2 revenue estimates, raises FY guidance - MarketScreener
Elanco Animal Health Reports Second Quarter 2025 Results - TradingView
Elanco raises full-year guidance on strength of newest products - Indianapolis Business Journal
Curious about Elanco Animal Health (ELAN) Q2 Performance? Explore Wall Street Estimates for Key Metrics - Yahoo Finance
What To Expect From Elanco’s (ELAN) Q2 Earnings - Yahoo Finance
P/E Ratio Insights for Elanco Animal Health - 富途牛牛
What catalysts could drive Elanco Animal Health Incorporated stock higher in 2025Build wealth steadily with proven investment techniques - Jammu Links News
Elanco Animal Health Inc Azioni (ELAN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Elanco Animal Health Inc Azioni (ELAN) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Kurzius Lawrence Erik | Director |
Mar 07 '25 |
Buy |
10.90 |
10,000 |
109,000 |
101,459 |
| Kurzius Lawrence Erik | Director |
Mar 11 '25 |
Buy |
10.20 |
10,000 |
102,000 |
111,459 |
| HOOVER R DAVID | Director |
Mar 05 '25 |
Buy |
10.90 |
25,000 |
272,558 |
210,000 |
| Harrington Michael J | Director |
Aug 22 '24 |
Buy |
14.85 |
3,500 |
51,974 |
81,094 |
2.19%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):